543 related articles for article (PubMed ID: 38434761)
1. Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy.
Zhuang H; Liang Z; Ma G; Qureshi A; Ran X; Feng C; Liu X; Yan X; Shen L
MedComm (2020); 2024 Mar; 5(3):e497. PubMed ID: 38434761
[TBL] [Abstract][Full Text] [Related]
2. A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneity.
Tang X; Feng C; Zhao Y; Zhang H; Gao Y; Cao X; Hong Q; Lin J; Zhuang H; Feng Y; Wang H; Shen L
MedComm (2020); 2023 Oct; 4(5):e380. PubMed ID: 37752942
[TBL] [Abstract][Full Text] [Related]
3. Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification.
Mesleh AG; Abdulla SA; El-Agnaf O
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33450950
[TBL] [Abstract][Full Text] [Related]
4. Oxidative Stress in Autism Spectrum Disorder-Current Progress of Mechanisms and Biomarkers.
Liu X; Lin J; Zhang H; Khan NU; Zhang J; Tang X; Cao X; Shen L
Front Psychiatry; 2022; 13():813304. PubMed ID: 35299821
[TBL] [Abstract][Full Text] [Related]
5. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy.
Wang L; Wang B; Wu C; Wang J; Sun M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768153
[TBL] [Abstract][Full Text] [Related]
6. Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.
McCracken JT; Anagnostou E; Arango C; Dawson G; Farchione T; Mantua V; McPartland J; Murphy D; Pandina G; Veenstra-VanderWeele J;
Eur Neuropsychopharmacol; 2021 Jul; 48():3-31. PubMed ID: 34158222
[TBL] [Abstract][Full Text] [Related]
7. New Strategies for Clinical Trials in Autism Spectrum Disorder.
Pauly R; Ziats CA; Abenavoli L; Schwartz CE; Boccuto L
Rev Recent Clin Trials; 2021; 16(2):131-137. PubMed ID: 33222679
[TBL] [Abstract][Full Text] [Related]
8. New and Preliminary Evidence on Altered Oral and Gut Microbiota in Individuals with Autism Spectrum Disorder (ASD): Implications for ASD Diagnosis and Subtyping Based on Microbial Biomarkers.
Kong X; Liu J; Cetinbas M; Sadreyev R; Koh M; Huang H; Adeseye A; He P; Zhu J; Russell H; Hobbie C; Liu K; Onderdonk AB
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31489949
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in autism spectrum disorders: Current progress.
Shen L; Liu X; Zhang H; Lin J; Feng C; Iqbal J
Clin Chim Acta; 2020 Mar; 502():41-54. PubMed ID: 31857069
[TBL] [Abstract][Full Text] [Related]
10. Leveraging Existing 16SrRNA Microbial Data to Define a Composite Biomarker for Autism Spectrum Disorder.
Xu Y; Wang Y; Xu J; Song Y; Liu B; Xiong Z
Microbiol Spectr; 2022 Aug; 10(4):e0033122. PubMed ID: 35762814
[TBL] [Abstract][Full Text] [Related]
11. Targeted Biomedical Treatment for Autism Spectrum Disorders.
Pacheva I; Ivanov I
Curr Pharm Des; 2019; 25(41):4430-4453. PubMed ID: 31801452
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.
Bjørklund G; Meguid NA; El-Ansary A; El-Bana MA; Dadar M; Aaseth J; Hemimi M; Osredkar J; Chirumbolo S
J Mol Neurosci; 2018 Dec; 66(4):492-511. PubMed ID: 30357679
[TBL] [Abstract][Full Text] [Related]
13. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
Bhandari R; Paliwal JK; Kuhad A
Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
[TBL] [Abstract][Full Text] [Related]
14. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
Aishworiya R; Valica T; Hagerman R; Restrepo B
Neurotherapeutics; 2022 Jan; 19(1):248-262. PubMed ID: 35029811
[TBL] [Abstract][Full Text] [Related]
15. A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children.
Shen L; Zhang H; Lin J; Gao Y; Chen M; Khan NU; Tang X; Hong Q; Feng C; Zhao Y; Cao X
Mol Neurobiol; 2022 Jun; 59(6):3529-3545. PubMed ID: 35348996
[TBL] [Abstract][Full Text] [Related]
16. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
[TBL] [Abstract][Full Text] [Related]
17. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.
Aishworiya R; Valica T; Hagerman R; Restrepo B
Focus (Am Psychiatr Publ); 2024 Apr; 22(2):198-211. PubMed ID: 38680976
[TBL] [Abstract][Full Text] [Related]
18. Shared and divergent contribution of vitamin A and oxytocin to the aetiology of autism spectrum disorder.
Wang T; Liu L; Fan T; Xia K; Sun Z
Comput Struct Biotechnol J; 2023; 21():3109-3123. PubMed ID: 38213898
[TBL] [Abstract][Full Text] [Related]
19. Research Progress on the Role of Vitamin D in Autism Spectrum Disorder.
Wang J; Huang H; Liu C; Zhang Y; Wang W; Zou Z; Yang L; He X; Wu J; Ma J; Liu Y
Front Behav Neurosci; 2022; 16():859151. PubMed ID: 35619598
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
